Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes
- PMID: 27754946
- DOI: 10.1161/CIRCULATIONAHA.115.020252
Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes
Abstract
Background: The RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes) is a prospective, outcomes-oriented registry designed to document the prevalence of atrial tachycardia and/or fibrillation (AT/AF) of any duration in patients with pacemakers and implantable cardioverter defibrillators (ICDs) and evaluate associations between rigorously adjudicated AT/AF and predefined clinical events, including stroke. The appropriate clinical response to brief episodes of AT/AF remains unclear.
Methods: Rigorously adjudicated electrogram (EGM) data were correlated with adjudicated clinical events with logistic regression and Cox models. Long episodes of AT/AF were defined as episodes in which the onset and/or offset of AT/AF was not present within a single EGM recording. Short episodes of AT/AF were defined as episodes in which both the onset and offset of AT/AF were present within a single EGM recording.
Results: We enrolled 5379 patients with pacemakers (N=3141) or ICDs (N=2238) at 225 US sites (median follow-up 22.9 months). There were 359 deaths. There were 478 hospitalizations among 342 patients for clinical events. We adjudicated 37 531 EGMs; 50% of patients had at least one episode of AT/AF. Patients with clinical events were more likely than those without to have long AT/AF (31.9% vs. 22.1% for pacemaker patients and 28.7% vs. 20.2% for ICD patients; P<0.05 for both groups). Only short episodes of AT/AF were documented in 9% of pacemaker patients and 16% of ICD patients. Patients with clinical events were no more likely than those without to have short AT/AF (5.1% vs. 7.9% for pacemaker patients and 11.5% vs. 10.4% for ICD patients; P=0.21 and 0.66, respectively).
Conclusions: In the RATE Registry, rigorously adjudicated short episodes of AT/AF, as defined, were not associated with increased risk of clinical events compared with patients without documented AT/AF.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00837798.
Keywords: anti-coagulation; atrial fibrillation; defibrillators; pacemakers; stroke; trials.
© 2016 American Heart Association, Inc.
Similar articles
-
Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording.Europace. 2006 Nov;8(11):950-61. doi: 10.1093/europace/eul112. Europace. 2006. PMID: 17043069 Clinical Trial.
-
Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.Heart Rhythm. 2018 Nov;15(11):1601-1607. doi: 10.1016/j.hrthm.2018.06.027. Epub 2018 Jul 6. Heart Rhythm. 2018. PMID: 29981863 Clinical Trial.
-
Is competitive atrial pacing a possible trigger for atrial fibrillation? Observations from the RATE registry.Heart Rhythm. 2021 Jan;18(1):3-9. doi: 10.1016/j.hrthm.2020.07.028. Epub 2020 Jul 30. Heart Rhythm. 2021. PMID: 32738404
-
Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.Europace. 2015 Oct;17 Suppl 2:ii40-6. doi: 10.1093/europace/euv235. Europace. 2015. PMID: 26842114 Review.
-
Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.Card Electrophysiol Rev. 2003 Dec;7(4):341-4. doi: 10.1023/B:CEPR.0000023134.41562.79. Card Electrophysiol Rev. 2003. PMID: 15071249 Review.
Cited by
-
Remote Monitoring of Atrial High Rate Episodes in Pacemaker Patients. The Rapid Study Design.J Atr Fibrillation. 2018 Aug 31;11(2):2075. doi: 10.4022/jafib.2075. eCollection 2018 Aug. J Atr Fibrillation. 2018. PMID: 30505383 Free PMC article.
-
Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation.J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3116-3125. doi: 10.19102/icrm.2018.090404. eCollection 2018 Apr. J Innov Card Rhythm Manag. 2018. PMID: 32477807 Free PMC article. Review.
-
Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality.Arrhythm Electrophysiol Rev. 2021 Jul;10(2):68-76. doi: 10.15420/aer.2021.01. Arrhythm Electrophysiol Rev. 2021. PMID: 34401178 Free PMC article. Review.
-
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30. Circulation. 2024. PMID: 38033089 Free PMC article.
-
The Future of Ischemic Stroke Diagnosis and a Review of Underrecognized Ischemic Stroke Etiologies.Neurotherapeutics. 2023 Apr;20(3):613-623. doi: 10.1007/s13311-023-01383-3. Epub 2023 May 8. Neurotherapeutics. 2023. PMID: 37157043 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical